Cielen Nele, Maes Karen, Gayan-Ramirez Ghislaine
Respiratory Muscle Research Unit, Laboratory of Pneumology and Respiratory Division, Department of Clinical and Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.
Biomed Res Int. 2014;2014:965764. doi: 10.1155/2014/965764. Epub 2014 Mar 25.
Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by airway obstruction and inflammation but also accompanied by several extrapulmonary consequences, such as skeletal muscle weakness and osteoporosis. Skeletal muscle weakness is of major concern, since it leads to poor functional capacity, impaired health status, increased healthcare utilization, and even mortality, independently of lung function. Osteoporosis leads to fractures and is associated with increased mortality, functional decline, loss of quality of life, and need for institutionalization. Therefore, the presence of the combination of these comorbidities will have a negative impact on daily life in patients with COPD. In this review, we will focus on these two comorbidities, their prevalence in COPD, combined risk factors, and pathogenesis. We will try to prove the clustering of these comorbidities and discuss possible preventive or therapeutic strategies.
慢性阻塞性肺疾病(COPD)是一种以气道阻塞和炎症为特征的肺部疾病,但也伴有多种肺外后果,如骨骼肌无力和骨质疏松症。骨骼肌无力是一个主要问题,因为它会导致功能能力下降、健康状况受损、医疗保健利用率增加,甚至导致死亡,而这与肺功能无关。骨质疏松症会导致骨折,并与死亡率增加、功能衰退、生活质量下降以及需要入住机构护理有关。因此,这些合并症的存在会对COPD患者的日常生活产生负面影响。在这篇综述中,我们将聚焦于这两种合并症、它们在COPD中的患病率、合并风险因素以及发病机制。我们将试图证明这些合并症的聚集性,并讨论可能的预防或治疗策略。